Astellas Pharma H-1B Visa Sponsorship 2026
Pharma & biotech Β· H-1B sponsor Β· FY2017β2026
π’ Northbrook, IL HQπ astellas.com
Does Astellas Pharma sponsor H-1B visas and green cards?
Yes. Astellas Pharma has filed 178 H-1B LCAs and 40 PERM green-card cases with the U.S. Department of Labor between FY2017 and FY2026. In FY2025β2026 Astellas Pharma filed 44 H-1B LCAs at a median base salary of $159,430, about 31% above the national H-1B median of $121,966 for the same period, and 16 green-card cases were decided.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 16 | $147k |
| FY2025 | 28 | $168k |
| FY2024 | 26 | $136k |
| FY2023 | 18 | $130k |
| FY2022 | 25 | $125k |
| FY2021 | 14 | $138k |
| FY2020 | 16 | $132k |
| FY2019 | 19 | $128k |
| FY2018 | 9 | $130k |
| FY2017 | 7 | $132k |
A fiscal year marked partial is still in progress, so its total is lower than a complete year and the two are not comparable.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
- 1Clinical Study Manager6$130k
- 2Validation Specialist5$85k
- 3AIA Data Operations Sr. Manager3$125k
- 4Associate Regulatory Operations Manager3$99k
- 5Director, Operational Excellence3$200k
- 6EIR (Entrepreneur in Residence) Business Lead3$203k
- 7Manager, Biostatistics3$127k
- 8Principal Data Manager3$153k
Where they hire
Green-card (PERM) pay & filings by year
Median green-card offer (line) and PERM filing volume (bars), by fiscal year β
Show the numbers behind this chart
| Fiscal year | PERM filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 7 | $125k |
| FY2025 | 9 | $127k |
| FY2024 | 3 | $122k |
| FY2023 | 4 | $148k |
| FY2022 | 4 | $119k |
| FY2021 | 4 | $135k |
| FY2020 | 2 | $142k |
| FY2019 | 2 | $119k |
| FY2018 | 4 | $143k |
| FY2017 | 1 | $100k |
Green-card route and outcomes
Worker backgrounds Β· FY2017β2024
Where their green-card (PERM) workers studied & came from
Pay against the local market
Astellas Pharmaβs 10 most-filed occupations and metros, FY2018βFY2026. Its median base salary is 136% of the local BLS median for the same work.
| Occupation | Metro | Filings | Astellas Pharma pay | Local BLS medianβ‘ | vs market |
|---|---|---|---|---|---|
| Statisticians | Chicago, IL | 29 | $128,509 | $99,412 | 129% |
| Computer Occupations, All Other | Chicago, IL | 22 | $132,654 | $100,747 | 132% |
| Software Developers | Chicago, IL | 16 | $153,106 | $117,089 | 131% |
| Data Scientists | Chicago, IL | 12 | $156,228 | $109,570 | 143% |
| Compliance Officers | Chicago, IL | 5 | $101,849 | $79,252 | 129% |
| Market Research Analysts and Marketing Specialists | San Francisco, CA | 4 | $123,126 | $104,020 | 118% |
| Biological Scientists, All Other | Boston, MA | 4 | $173,298 | $103,120 | 168% |
| Natural Sciences Managers | Chicago, IL | 4 | $152,612 | $131,480 | 116% |
| General and Operations Managers | Chicago, IL | 4 | $225,100 | $110,525 | 204% |
| Medical and Health Services Managers | Chicago, IL | 3 | $316,430 | $122,267 | 259% |
About Astellas Pharma
Astellas Pharma is a pharma & biotech company based in ChΕ«Ε, Japan. It was founded in 2005. It is listed on Tokyo Stock Exchange as 4503.
- Legal name
- Astellas Pharma Inc
- Listed
- Private
- Incorporated in
- M0
- Headquarters
- 60 Wall Street, New York, NY 10005
- Industry
- Pharma & biotech
- Founded
- 2005
- H-1B filings
- 178
- Median base
- $135,564
- Website
- astellas.com
Astellas Pharma pays a median H-1B base of $135,564 across FY2017β2026, about 25% above the typical Pharma & biotech sponsor.
H-1B sponsors similar to Astellas Pharma
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Climate | 307 | 25 | $157k | 2 | 86% |
| Intellia Therapeutics | 292 | 21 | $142k | 4 | 95% |
| Corteva | 271 | 87 | $114k | 44 | 83% |
| Astellas Pharma | 178 | 44 | $159k | 19 | 73% |
| Sun Pharmaceutical | 177 | 23 | $101k | 5 | 52% |
| Belcher Pharmaceuticals | 176 | 32 | $84k | 8 | 47% |
| Spino | 175 | 23 | $90k | 5 | 17% |
